Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

UBS Maintains Neutral on CareMax, Lowers Price Target to $6.4

Author: Benzinga Newsdesk | April 01, 2024 09:24am

UBS analyst A.J. Rice maintains CareMax (NASDAQ:CMAX) with a Neutral and lowers the price target from $7 to $6.4.

Posted In: CMAX